| Literature DB >> 23532355 |
Paul M Arnold1, Lisa R Rice, Karen K Anderson, Joan K McMahon, Lynne M Connelly, Daniel C Norvell.
Abstract
STUDYEntities:
Year: 2011 PMID: 23532355 PMCID: PMC3604758 DOI: 10.1055/s-0030-1267108
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig. 1Patient sampling and selection.
Baseline demographics and general health characteristics of patients undergoing cervical fusion*.
| Characteristic | Patients (N = 103), No. (%) or mean ± SD |
|---|---|
| Female | 56 (54) |
| Age, y | 49.1 ± 9.9 |
| Height, in | 67.3 ± 4.1 |
| Weight, kg | 87.1 ± 19.1 |
| Smoke, packs per day | .38 ± .60 |
| Regular alcohol use, yes | 14 (14) |
| Previous spine surgery | 17 (17) |
| Psychiatric issues | 25 (24) |
| Respiratory | 17 (17) |
| Degenerative joint disease | 2 (2) |
| Cervical spondylotic myelopathy | 51 (50) |
| Herniated nucleus pulposus | 65 (63) |
| Stenosis | 35 (34) |
| Central nervous system | 25 (24) |
| Diabetes | 12 (12) |
| Gastrointestinal | 25 (24) |
| Cardiovascular disease | 45 (44) |
| Genitourinary | 11 (11) |
| Cancer | 3 (3) |
Missing 11 height and 2 weight data points.
Including myelopathy, radiculopathy, and myeloradiculopathy.
Herniated disc, degenerative disc disease, spondylosis, osteophytes.
Baseline pain and symptoms of patients undergoing cervical fusion*.
| Characteristic | Patients (N = 103), No. (%) |
|---|---|
| Neck pain | 78 (76) |
| UE pain | 75 (73) |
| Unilateral UE numbness | 37 (36) |
| Bilateral UE numbness | 16 (16) |
| Unilateral UE weakness | 16 (16) |
| Bilateral UE weakness | 3 (3) |
| Unilateral LE numbness | 5 (5) |
| Bilateral LE numbness | 2 (2) |
| Unilateral LE weakness | 3 (3) |
| Bilateral LE weakness | 3 (3) |
| Ambulation difficulty | 5 (5) |
| Symptom duration (short) | 24 (23) |
| Symptom duration (medium) | 16 (16) |
| Symptom duration (long) | 29 (28) |
UE indicates upper extremity; LE, lower extremity.
Surgery-specific characteristics of patients undergoing cervical fusion*.
| Factor | Patients (N = 103), |
|---|---|
| 1.98 ± 1.6 | |
| 3.4 ± .99 | |
| | |
| 87.4 ± 99.6 | |
| | |
| | |
| |
NSAIDS indicates nonsteroidal antiinflammatory drugs; IV, intravenous.
One patient had 700 mL blood loss and was treated with iron tid.
Postoperative complications after cervical spine fusion.
| Complications | Patients (N = 103), No. (%) |
|---|---|
| Any complication | 77 (75) |
| Neurological | 1 (1) |
| Dysphagia | 2 (2) |
| Cardiac | 6 (6) |
| Urinary | 3 (3) |
| Anxiety | 1 (1) |
| Pulmonary | 4 (4) |
| Fever | 2 (2) |
| Pain | 13 (13) |
Multivariate linear regression analysis of length of stay (in days) as outcome with all covariates that have an association of P < .05.
| Covariate | Mean Days, | Model R2 | |
|---|---|---|---|
| ≤50 | .001 | .48 | |
| Male | .011 | ||
| No | .002 | ||
| No | <.001 | ||
| No | <.001 | ||
Adjusted for other variables in the model.
| Final class of evidence (CoE)-treatment | Yes |
|---|---|
| Study design: | |
| Prospective cohort | |
| Retrospective cohort | • |
| Case control | |
| Case series | |
| Methods | |
| Patients at similar point in course of treatment | • |
| Follow-up ≥85% | • |
| Similarity of treatment protocols for patient groups | • |
| Patients followed-up long enough for outcomes to occur | • |
| Control for extraneous risk factors | • |
| The definiton of the different classes of evidence is available on page 59. | |